Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Clear Gene, Inc. develops molecular diagnostic tests utilizing genomics and machine learning to detect residual solid tumors, particularly in patients with breast cancer. Their key products include…

Clear Gene, Inc. develops molecular diagnostic tests utilizing genomics and machine learning to detect residual solid tumors, particularly in patients with breast cancer. Their key products include…
Headquarters: San Carlos, California
Industry: Biotechnology / Genomics / Machine Learning for diagnostics
Stage / Size: Early-stage (Seed); 1–10 employees
Products: MICA Software™, MICA Test Kits, MICA–Direct™ Kits
Focus: Molecular diagnostics for residual solid tumor detection and lab workflows
Residual disease detection in solid tumors and laboratory workflow optimization for diagnostics.
2012
Biotechnology
Public profiles indicate two funding rounds recorded; specific amounts/details are obfuscated on public views.
Profile metadata lists a last funding date of 2021-12-01 on company snapshot.
“Investors include Unpopular Ventures and Founders, Inc.; Crunchbase lists three investors”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week